Welcome back to our blog series on National Member News!

We are excited about getting our National Member news out to the world, so more people can find out what it is happening in each country and each member organisation! We caught up with Ram Blass from Inbar who talked to us about the wonderful work the organisation is doing, the needs of lupus patients in Israel,  lupus and sun sensitivity and much more!

 

How do you keep in touch with or have contact with your members?

 

Most of the time we keep in touch through whatsapp and facebook. We have two facebook groups for lupus specifically; one of those groups has over 1500 members and the other one around 1000 members. Sharon moderates one of the groups and does a very good job of it!

 

Did you have any special meetings or webinars during the past year (World Lupus Day, Rare Disease Day, Annual General Meeting etc)?

 

Absolutely! We run webinars 3 times a year on lupus specifically and we did that last year too. In the past year we also had webinars on covid19.  We regularly also run webinars about rheumatic diseases in general.

 

We have to say that within our organisation, INBAR, we also have a group about scleroderma, as a rare disease, and this is building up at the moment. Another group within our organisation that we also have is a group on Familial Mediterranean Fever (FMF). We therefore regularly run webinars on those conditions too and many others!

 

Has it been difficult to keep connected with your members during the Covid19 pandemic?

 

Most of our members have been home during the pandemic. It wasn’t very hard to have a connection with our members during the pandemic. We used Zoom, Facebook and whatsapp and connected regularly with our members through those mediums; it wasn’t hard at all to stay connected.

 

We also have e-mails for all of our members and we regularly connect with our members through e-mails as well.

 

During the pandemic we established two lupus specific support groups; they are divided according to age, one is for over 45s for example. We run the support groups over zoom. Both support groups meet weekly for 12 weeks and after those 12 weeks they have monthly meetings. Th

 

Have there been any circumstances during the pandemic that changed the way of living with lupus?

 

 Yes, absolutely. One big difference that naturally came about with the pandemic is that everyone is much more helpful. People are also more reluctant to leave their houses and the pandemic made things that much more difficult for everybody in that way. People with autoimmune conditions like lupus were a lot more careful during the pandemic. We, as an organisation, warned people many times to protect themselves against covid and be careful because it can be very difficult if lupus patients catch covid19. People were scared for a long time, but now everything seems to be settling down and restrictions easing.

 

We have had a lot of questions come to us about vaccination against covid. In fact, people still have questions. We had a webinar on vaccination specifically, one of the professors spoke and said it’s important for everyone to have the vaccine. He also able to advise about specific medication and the vaccine and encouraged people to ask their own doctor about the vaccine. We have found that most lupus patients that are INBAR members have taken the vaccine.

 

Has Digital Health improved or changed in your country?

 

Yes! Digital health has changed over the past few years, it has greatly improved. We are connected to our national health service now and we can receive the results of tests online for example! Patients also have the choice to communicate with their doctors by phone or by zoom or in person. Electronic prescriptions are also available, and they are widely used. Everything has changed, and we think this will be maintained in the future, as the systems are there now to accommodate these changes. 

 

What would you most need as support in your country for lupus?

 

Although things have improved greatly in the last few years, we always appreciate receiving all the latest news and updates. We believe the synergy of working together is very important. Working together is so much better than each organisation and each country working alone.

 

Is there anything you think Lupus Europe could help your organisation with?  

 

We are a very diverse country in terms of the languages spoken here. Everyone speaks Hebrew, though not everyone speaks it fluently, and a lot of people speak English, Arabic or French. We would be very happy if there could be translations of important documents about lupus and information on lupus in Hebrew. It would be of important benefit to us and our members if we could receive some information in Hebrew. 

 

Is there any topic/theme/area that you think Lupus Europe should focus on, on something where European collaboration would make sense?

Yes, we would want a central database of information to be created that could be open to all members, like a library of information. Each member could contribute and be able to access information through this library.

 

We would be very keen to have Lupus Europe focus on issues like sun sensitivity of lupus patients and also pollution, as we believe pollution is involved in autoimmunity and lupus.

 

Are you aware of the Lupus Europe Member Capacity Building Program?

 

No! But now we are! 

 

Could you tell us a bit about a dream you have as a group?

 

The dream of our group is that everybody will be healthy. We know that this is impossible, but an important dream for us is for everyone to be in remission.  We believe this to be possible and we hope a lot more new medication will be available in the future for lupus and for other autoimmune diseases.

 

 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

💜 We've taken part in the EULAR PARE Conference 2026 in Brussels! And what an interesting opportunity to discuss the future of AI in healthcare!

🌍 Bringing together more than 100 delegates and speakers from across Europe and beyond, the conference explored some of the most important questions surrounding artificial intelligence in rheumatology and patient advocacy.

From the opportunities and risks of AI to health inequalities, accessibility and European health policy, the discussions highlighted why patient perspectives must be part of the conversation.

🤩 We were particularly proud to see Jeanette Andersen, Chair of the Lupus Europe Board, sharing our experience with #LupusGPT in her presentation, “AI as a Partner in Care: Empowering the RMD Community with Information”.

💡 Jeanette explained how #LupusGPT was developed with patients and clinicians to offer free, multilingual access to reliable lupus information based on validated sources.

She also introduced #EasyLupus, which provides the same trusted information in simpler language, highlighting why accessibility must be considered when developing AI tools.

But one of the most important messages from her presentation went beyond technology.

💜 Patient organisations have much more to contribute to AI than simply using tools developed by others.

As Jeanette highlighted, patient organisations bring lived experience, knowledge of unmet needs, trusted information and an understanding of the barriers people face when accessing health information.

Technology alone cannot tell us what patients really need or what makes a tool genuinely useful.

Patients and patient organisations should not simply be users of AI. They should help shape its development.

👏 A big thank you to EULAR PARE for bringing together so many different perspectives and creating space for meaningful discussions about the future of healthcare and patient involvement!
...

💜 Weve taken part

🦋 One of the greatest strengths of patient organisations is the support, understanding and sense of community they offer to people living with lupus. 💜

🇧🇬 A great example comes from Организация на пациентите с ревматологични заболявания, who shared their psychological support initiative at the #LupusConvention!

💜 Launched in December 2025, this pilot project provides a safe and supportive space where participants can share their experiences and discuss the challenges of living with lupus, from fatigue and anxiety to relationships and everyday life.

👥 Led by a clinical psychologist, the group currently brings together six women. The project is expected to run until December 2026, while the organisation explores funding opportunities to continue and expand the initiative.

Thank you to our Bulgarian colleagues for sharing their experience, and congratulations on the amazing job you are doing! ❤️

🌍 This is just one example of the valuable work patient organisations are doing across Europe, often responding to needs that go beyond medical care. We'll share more in the coming days!

💜 Are you living with lupus? You don't have to navigate everything alone! Your national lupus organisation may offer information, support, activities and opportunities to connect with others who understand your experiences.

🔗 Find your national lupus organisation and get in touch:
lupus-europe.org/lupus-members/
...

Image attachment
Image attachment

💜 Young people living with lupus are not only the future of patient advocacy. Their voices matter today!

On 23 and 24 October, LUPUS EUROPE was delighted to be represented at the first 𝗘𝗣𝗙 𝗬𝗼𝘂𝘁𝗵 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟲 in Brussels by Ana Rita Vieira, from the LUPUS EUROPE Youth Group, and Lena Koskina, LUPUS EUROPE's Youth Group Coordinator.

🌍 Organised by European Patients' Forum and its EPF Youth Group, the Congress brought together young patient advocates from across Europe to explore the challenges facing young people living with chronic conditions, from economic uncertainty and climate change to the barriers they encounter when trying to influence healthcare decisions.

🌟 One particularly important question ran through the discussions: 𝗵𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗺𝗼𝘃𝗲 𝗯𝗲𝘆𝗼𝗻𝗱 𝘀𝗶𝗺𝗽𝗹𝘆 𝗴𝗶𝘃𝗶𝗻𝗴 𝘆𝗼𝘂𝗻𝗴 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮 𝘀𝗲𝗮𝘁 𝗮𝘁 𝘁𝗵𝗲 𝘁𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗲𝗻𝘀𝘂𝗿𝗲 𝘁𝗵𝗲𝘆 𝗵𝗮𝘃𝗲 𝗮 𝗿𝗲𝗮𝗹 𝘀𝗮𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗯𝗲𝗶𝗻𝗴 𝗺𝗮𝗱𝗲❓

The conversations also highlighted something easily overlooked: 𝗺𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮𝗻 𝗶𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻. Young people living with chronic conditions are often balancing their health with education, employment and financial pressures. Advocacy opportunities need to recognise those realities, and not be accessible only to those who can afford the time and resources to participate.

🦋 At LUPUS EUROPE, supporting the Youth Group means actively helping create those opportunities, connecting young advocates with others across Europe and ensuring their perspectives can meaningfully contribute to the work we do.

Young people living with lupus are already advocates, bringing their experiences, ideas and knowledge into conversations that matter.

💜 Thank you to European Patients' Forum and its EPF Youth Group for bringing everyone together, and to Rita and Lena for representing LUPUS EUROPE at this important Congress!
...

💜 Young people li

🔊 Hot off the press!

💜 Treatment adherence is important, complex and multifactorial.

But understanding the importance of treatment adherence is not the same as knowing how to support it in everyday clinical practice.

That’s why, in 2020, EULAR published its Points to Consider for the prevention, screening, assessment and management of nonadherence to treatment in people with rheumatic and musculoskeletal diseases.

But having recommendations is only the first step. How can we ensure they become part of everyday clinical practice?

🤩 An interesting new viewpoint published in EULAR Rheumatology Open, co-authored by Jeanette Andersen, Chair of the Lupus Europe Board, now explores the challenges of putting these recommendations into routine rheumatology care.

The article highlights that nonadherence is not simply a matter of individual patient behaviour. Concerns about treatment, practical difficulties, access to medication, socioeconomic circumstances and communication with healthcare professionals can all play a role.

The authors highlight five key priorities for putting adherence support into routine rheumatology practice:

🔹 Assessment: Identifying adherence behaviours and the barriers behind them.
🔹 Monitoring: Reassessing adherence over time, as it may change throughout the disease course.
🔹 Shared decision-making: Discussing patients’ preferences, expectations and concerns through non-judgemental communication.
🔹 Multidisciplinary care: Involving the wider healthcare team according to individual needs.
🔹 Training: Making adherence support part of rheumatology education and professional development.

💜 The challenge is not the lack of recommendations, but making adherence assessment and support a routine part of rheumatology care.

📖 Read the open-access viewpoint: doi.org/10.1016/j.ero.2026.100261
...

Image attachment
Image attachment
Image attachment
Image attachment
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send